9月12日 - ** 药物开发商 Anebulo 制药公司ANEB.O的股票在早盘交易中上涨 16.9% 至 2.35 美元
** Anebulo Pharmaceuticals称 (link)，在2025年7月首次宣布私有化计划后，该公司仍在考虑私有化计划，但也收到了可能的买家和合作伙伴的兴趣
** 该公司表示，公司董事会将审议不同的方案，以实现股东价值最大化，包括私有化交易与反向股票分割、潜在的资产出售或合并。
** 截至上次收盘，ANEB 年累计下跌 19.6
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.